MARKET

TBPH

TBPH

Theravance
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.22
-0.34
-1.94%
Closed 16:05 11/12 EST
OPEN
17.55
PREV CLOSE
17.56
HIGH
17.65
LOW
17.10
VOLUME
326.76K
TURNOVER
--
52 WEEK HIGH
29.45
52 WEEK LOW
15.18
MARKET CAP
977.45M
P/E (TTM)
-4.3003
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TBPH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

TBPH News

  • Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2019 - Earnings Call Transcript
  • Seeking Alpha - Transcript.3d ago
  • Edited Transcript of TBPH earnings conference call or presentation 5-Nov-19 10:00pm GMT
  • Thomson Reuters StreetEvents.4d ago
  • Theravance Biopharma to Present at the 2019 Credit Suisse Healthcare Conference
  • PR Newswire.6d ago
  • Theravance (TBPH) Q3 Loss In Line, Revenues Lag Estimates
  • Zacks.6d ago

More

Industry

Pharmaceuticals
+0.27%
Pharmaceuticals & Medical Research
+0.27%

Hot Stocks

Name
Price
%Change

About TBPH

Theravance Biopharma, Inc. is a biopharmaceutical company. The Company is engaged in creating medicines for patients suffering from serious illness. The Company operates in the segment of discovery (research), development and commercialization of human therapeutics. The Company's pipeline of internally discovered product candidates includes medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting. Its commercial product VIBATIV (telavancin) is a once-daily dual-mechanism antibiotic approved in the United States and Europe for certain difficult-to-treat infections. Its Revefenacin (TD-4208) is a long-acting muscarinic antagonist (LAMA) being developed as a nebulized treatment for chronic obstructive pulmonary disease. Its neprilysin (NEP) inhibitor program is designed to develop selective NEP inhibitors for the treatment of a range of cardiovascular and renal diseases.
More

Webull offers Theravance Biopharma Inc (TBPH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.